The biosensing platform developed by Penn State engineering researchers incorporates two-pass laser induced graphene with commercial transistors to simultaneously test for SARS-CoV-2 and vitamin C.

The COO and EVP of Dexcom, Jake Leach, had this to say about the development: The launch of our GenAI platform reinforces our long-standing reputation as the glucose biosensing leader and opens ...

Syntec Optics (OPTX) announced its continued collaboration to enable development of a novel photonic biosensing technology poised to transform ...

Syntec Optics Holdings, Inc. announced its collaboration on a new photonic biosensing technology that aims to revolutionize drug discovery and testing. By providing optical manufacturing support ...

XPANCEO has unveiled a trio of smart contact lens prototypes at MWC 2025 Technology showcased includes fully remote power ...

In a study published recently in npj Biosensing, researchers from Osaka University have revealed that high liquid flow rates could cause aggregation-prone proteins to start sticking together.

(NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March 6, 2025. Ms. Galá is an accomplished executive with ...

Traditional testing methods often fail to predict human responses accurately. By replacing current animal models and lab tests with precise, real-time photonic biosensing, development timelines can be ...

By replacing current animal models and lab tests with precise, real-time photonic biosensing, development timelines can be accelerated, and clinical trial costs can be lowered. Joel Lawther ...